Literature DB >> 21479680

Paracrine-mediated osteoclastogenesis by the osteosarcoma MG63 cell line: is RANKL/RANK signalling really important?

J Costa-Rodrigues1, C A Teixeira, M H Fernandes.   

Abstract

Although in the past little attention has been paid to the influence of osteosarcoma cells in osteoclast function, recent studies suggest a close relationship between osteosarcoma aggressiveness and osteoclastic activity. The present study addresses the paracrine effects of MG63 cells, a human osteosarcoma-derived cell line, on the differentiation of peripheral blood osteoclast precursor cells (PBMC). PBMC were cultured for 21 days in the presence of conditioned media from MG63 cell cultures (CM) collected at 48 h (CM_MG1), 7 days (CM_MG2) and 14 days (CM_MG3). MG63 cell cultures displayed the expression of ALP and BMP-2 and, also, the osteoclastogenic genes M-CSF and RANKL, although with a low expression of RANKL. PBMC cultures supplemented with CM presented an evident osteoclastogenic behavior, which was dependent on the culture period of the MG63 cells. The inductive effect appeared to be more relevant for the differentiation and activation genes, c-myc and c-src, and lower for genes associated with osteoclast function. In addition, PBMC cultures displayed increased functional parameters, including calcium phosphate resorbing activity. Assessment of the PBMC cultures in the presence of U0126, PDTC, and indomethacin suggested that in addition to MEK and NFkB pathways, other signaling mechanisms, probably not involving RANKL/RANK interaction, might be activated in the presence of conditioned medium from MG63. In conclusion, MG63 cell line appears to induce a significant paracrine-mediated osteoclastogenic response. Understanding the mechanisms underlying the interaction of osteosarcoma cells and osteoclasts may contribute to the development of new potential approaches in the treatment of such bone metabolic diseases.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21479680     DOI: 10.1007/s10585-011-9387-7

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  54 in total

Review 1.  Osteoclast differentiation and activation.

Authors:  William J Boyle; W Scott Simonet; David L Lacey
Journal:  Nature       Date:  2003-05-15       Impact factor: 49.962

2.  Characterisation of the osteoclastogenic potential of human osteoblastic and fibroblastic conditioned media.

Authors:  João Costa-Rodrigues; Cristina A Teixeira; Paula Sampaio; Maria H Fernandes
Journal:  J Cell Biochem       Date:  2010-01-01       Impact factor: 4.429

3.  Demonstration of alkaline phosphatase participation in the mineralization of osteoblasts by antisense RNA approach.

Authors:  Y Torii; K Hitomi; Y Yamagishi; N Tsukagoshi
Journal:  Cell Biol Int       Date:  1996-07       Impact factor: 3.612

4.  Simvastatin inhibits osteoclast differentiation induced by bone morphogenetic protein-2 and RANKL through regulating MAPK, AKT and Src signaling.

Authors:  Misuzu Yamashita; Fumio Otsuka; Tomoyuki Mukai; Ryutaro Yamanaka; Hiroyuki Otani; Yoshinori Matsumoto; Eri Nakamura; Mariko Takano; Ken-ei Sada; Hirofumi Makino
Journal:  Regul Pept       Date:  2010-03-24

5.  Immature osteoblastic MG63 cells possess two calcitonin gene-related peptide receptor subtypes that respond differently to [Cys(Acm)(2,7)] calcitonin gene-related peptide and CGRP(8-37).

Authors:  Tomoyuki Kawase; Kazuhiro Okuda; Douglas M Burns
Journal:  Am J Physiol Cell Physiol       Date:  2005-06-15       Impact factor: 4.249

6.  Importance of membrane- or matrix-associated forms of M-CSF and RANKL/ODF in osteoclastogenesis supported by SaOS-4/3 cells expressing recombinant PTH/PTHrP receptors.

Authors:  K Itoh; N Udagawa; K Matsuzaki; M Takami; H Amano; T Shinki; Y Ueno; N Takahashi; T Suda
Journal:  J Bone Miner Res       Date:  2000-09       Impact factor: 6.741

7.  Decoy receptor 3 (DcR3) induces osteoclast formation from monocyte/macrophage lineage precursor cells.

Authors:  C R Yang; J H Wang; S L Hsieh; S M Wang; T L Hsu; W W Lin
Journal:  Cell Death Differ       Date:  2004-07       Impact factor: 15.828

Review 8.  Bone metastasis: pathogenesis and therapeutic implications.

Authors:  Philippe Clezardin; Anna Teti
Journal:  Clin Exp Metastasis       Date:  2007-11-16       Impact factor: 5.150

9.  Tissue-nonspecific alkaline phosphatase and plasma cell membrane glycoprotein-1 are central antagonistic regulators of bone mineralization.

Authors:  Lovisa Hessle; Kristen A Johnson; H Clarke Anderson; Sonoko Narisawa; Adnan Sali; James W Goding; Robert Terkeltaub; José Luis Millan
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-24       Impact factor: 11.205

10.  Increased osteoclast activity is associated with aggressiveness of osteosarcoma.

Authors:  Sofia Avnet; Alessandra Longhi; Manuela Salerno; Jussi M Halleen; Francesca Perut; Donatella Granchi; Stefano Ferrari; Franco Bertoni; Armando Giunti; Nicola Baldini
Journal:  Int J Oncol       Date:  2008-12       Impact factor: 5.650

View more
  3 in total

Review 1.  Bone microenvironment signals in osteosarcoma development.

Authors:  Arantzazu Alfranca; Lucia Martinez-Cruzado; Juan Tornin; Ander Abarrategi; Teresa Amaral; Enrique de Alava; Pablo Menendez; Javier Garcia-Castro; Rene Rodriguez
Journal:  Cell Mol Life Sci       Date:  2015-05-03       Impact factor: 9.261

2.  Inhibition of human in vitro osteoclastogenesis by Equisetum arvense.

Authors:  J Costa-Rodrigues; S C Carmo; J C Silva; M H R Fernandes
Journal:  Cell Prolif       Date:  2012-12       Impact factor: 6.831

3.  Rosiglitazone via PPARγ-dependent suppression of oxidative stress attenuates endothelial dysfunction in rats fed homocysteine thiolactone.

Authors:  Xu-Hong Yang; Peng Li; Ya-Ling Yin; Jiang-Hua Tu; Wen Dai; Li-Ying Liu; Shuang-Xi Wang
Journal:  J Cell Mol Med       Date:  2015-02-05       Impact factor: 5.310

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.